Key result
Point-of-care troponin testing reduced emergency department length of stay by 48 minutes and increased the proportion of patients discharged within 8 hours by 10%.
Why the study?
Does cardiac troponin I testing with a point-of-care device reduce length of stay in emergency department patients presenting with possible acute coronary syndromes?
RCT
By week when POC was made available
Yes
Does cardiac troponin I testing with a point-of-care device reduce length of stay in emergency department patients presenting with possible acute coronary syndromes?
Point-of-care troponin testing significantly increases the proportion of patients with possible ACS discharged from the emergency department within 8 hours compared to central laboratory testing.
Answers are grounded in this paper and cite their sources.
Increases 8-hour discharges for possible ACS; extends RCT evidence supporting point-of-care troponin for ED efficiency.
OBJECTIVE: To determine the effect of cardiac troponin I testing with a point-of-care (POC) device versus central laboratory on length of stay (LOS) in emergency department (ED) patients presenting with possible acute coronary syndromes (ACS). METHODS: A 12-week randomised controlled trial at two metropolitan ED in eastern Australia with a combined annual census of 80,000. Participants were all patients presenting with possible ACS. Exclusions were a diagnosis of ACS before arrival, ST elevation and failure to wait for complete assessment. Randomisation was by week when POC was made available. Primary outcome was LOS from patient arrival to physical departure from the ED. The proportion of patients meeting a government target of less than 8 h stay was compared. Analysis was by intention to treat. RESULTS: Despite underutilisation of POC, LOS was shorter during weeks when it was available. The time savings translates into approximately 48 minutes (95% CI 12 to 84) per average LOS of almost 7 h, which did not reach statistical significance (p=0.063), or an absolute increase of 10% (95% CI 4.3 to 16.6) in the number of people discharged from the ED within the target LOS of less than 8 h, which did reach significance (p=0.007). These savings were more pronounced in the setting without 24 h central laboratory availability. CONCLUSIONS: POC testing for troponin in the ED tended to reduce the LOS for possible ACS patients. The degree of this benefit is likely to be markedly dependent on its acceptance and uptake by attending personnel, and on the ED setting in which it is used.
No takes yet. Share an insight, caveat, or question.
Loten et al. (2010) conducted an RCT in Possible acute coronary syndromes (ACS). Point-of-care (POC) cardiac troponin I testing vs. Central laboratory testing was evaluated on Length of stay from patient arrival to physical departure from the ED (MD 48 minutes savings, 95% CI 12 to 84, p=0.063). Point-of-care troponin testing reduced emergency department length of stay by 48 minutes and increased the proportion of patients discharged within 8 hours by 10%.
Synapse has enriched 10 related papers. Consider them for comparative context: